 | • レポートコード：QYR9ST08785 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、腫瘍学バイオマーカーの世界市場について調査・分析し、腫瘍学バイオマーカーの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（肺癌、乳癌、大腸癌、前立腺癌、胃癌、その他）、用途別（診断、医薬品発見及び開発、予後、リスク評価、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腫瘍学バイオマーカー市場動向 ・主要企業別マーケットシェア ・腫瘍学バイオマーカーの種類別市場規模2014-2019 （肺癌、乳癌、大腸癌、前立腺癌、胃癌、その他） ・腫瘍学バイオマーカーの用途別市場規模2014-2019 （診断、医薬品発見及び開発、予後、リスク評価、その他） ・腫瘍学バイオマーカーの北米市場：主要企業・種類別/用途別市場規模 ・腫瘍学バイオマーカーのヨーロッパ市場：主要企業・種類別/用途別市場規模 ・腫瘍学バイオマーカーの中国市場：主要企業・種類別/用途別市場規模 ・腫瘍学バイオマーカーの日本国内市場：主要企業・種類別/用途別市場規模 ・腫瘍学バイオマーカーの東南アジア市場：主要企業・種類別/用途別市場規模 ・腫瘍学バイオマーカーのインド市場：主要企業・種類別/用途別市場規模 ・腫瘍学バイオマーカーの中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Abbott Laboratories、Bristol-Myers Squibb、Eli Lilly and Company、F.Hoffmann-La Roche Ltd.、Genomic Health、GlaxoSmithKline plc、Novartis AG、Merck & Co.、Pfizer、Qiagen N.V.） ・腫瘍学バイオマーカーの市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
A biomarker is referred to as a traceable biomolecule, whose presence found in body fluids such as blood, serum, urine, and tumor fluid that indicates disease or an underlying condition such as cancer.In 2018, the global Oncology Biomarker market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Oncology Biomarker status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncology Biomarker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Abbott Laboratories
Bristol-Myers Squibb
Eli Lilly and Company
F.Hoffmann-La Roche Ltd.
Genomic Health
GlaxoSmithKline plc
Novartis AG
Merck & Co.
Pfizer
Qiagen N.V.
Market segment by Type, the product can be split into
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Stomach Cancer
Others
Market segment by Application, split into
Diagnostics
Drug Discovery And Development
Prognostics
Risk Assessment
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Oncology Biomarker status, future forecast, growth opportunity, key market and key players.
To present the Oncology Biomarker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Oncology Biomarker are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Oncology Biomarker Market Size Growth Rate by Type (2014-2025)
1.4.2 Lung Cancer
1.4.3 Breast Cancer
1.4.4 Colorectal Cancer
1.4.5 Prostate Cancer
1.4.6 Stomach Cancer
1.4.7 Others
1.5 Market by Application
1.5.1 Global Oncology Biomarker Market Share by Application (2019-2025)
1.5.2 Diagnostics
1.5.3 Drug Discovery And Development
1.5.4 Prognostics
1.5.5 Risk Assessment
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Oncology Biomarker Market Size
2.2 Oncology Biomarker Growth Trends by Regions
2.2.1 Oncology Biomarker Market Size by Regions (2019-2025)
2.2.2 Oncology Biomarker Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Oncology Biomarker Market Size by by Players
3.1.1 Global Oncology Biomarker Revenue by by Players (2014-2019)
3.1.2 Global Oncology Biomarker Revenue Market Share by by Players (2014-2019)
3.1.3 Global Oncology Biomarker Market Concentration Ratio (CR5 and HHI)
3.2 Oncology Biomarker Key Players Head office and Area Served
3.3 Key Players Oncology Biomarker Product/Solution/Service
3.4 Date of Enter into Oncology Biomarker Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Oncology Biomarker Market Size by Type (2014-2019)
4.2 Global Oncology Biomarker Market Size by Application (2014-2019)
5 North America
5.1 North America Oncology Biomarker Market Size (2014-2019)
5.2 Oncology Biomarker Key Players in North America
5.3 North America Oncology Biomarker Market Size by Type
5.4 North America Oncology Biomarker Market Size by Application
6 Europe
6.1 Europe Oncology Biomarker Market Size (2014-2019)
6.2 Oncology Biomarker Key Players in Europe
6.3 Europe Oncology Biomarker Market Size by Type
6.4 Europe Oncology Biomarker Market Size by Application
7 China
7.1 China Oncology Biomarker Market Size (2014-2019)
7.2 Oncology Biomarker Key Players in China
7.3 China Oncology Biomarker Market Size by Type
7.4 China Oncology Biomarker Market Size by Application
8 Japan
8.1 Japan Oncology Biomarker Market Size (2014-2019)
8.2 Oncology Biomarker Key Players in Japan
8.3 Japan Oncology Biomarker Market Size by Type
8.4 Japan Oncology Biomarker Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Oncology Biomarker Market Size (2014-2019)
9.2 Oncology Biomarker Key Players in Southeast Asia
9.3 Southeast Asia Oncology Biomarker Market Size by Type
9.4 Southeast Asia Oncology Biomarker Market Size by Application
10 India
10.1 India Oncology Biomarker Market Size (2014-2019)
10.2 Oncology Biomarker Key Players in India
10.3 India Oncology Biomarker Market Size by Type
10.4 India Oncology Biomarker Market Size by Application
11 Central & South America
11.1 Central & South America Oncology Biomarker Market Size (2014-2019)
11.2 Oncology Biomarker Key Players in Central & South America
11.3 Central & South America Oncology Biomarker Market Size by Type
11.4 Central & South America Oncology Biomarker Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Oncology Biomarker Introduction
12.1.4 Abbott Laboratories Revenue in Oncology Biomarker Business (2014-2019))
12.1.5 Abbott Laboratories Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Oncology Biomarker Introduction
12.2.4 Bristol-Myers Squibb Revenue in Oncology Biomarker Business (2014-2019)
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Eli Lilly and Company
12.3.1 Eli Lilly and Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Oncology Biomarker Introduction
12.3.4 Eli Lilly and Company Revenue in Oncology Biomarker Business (2014-2019)
12.3.5 Eli Lilly and Company Recent Development
12.4 F.Hoffmann-La Roche Ltd.
12.4.1 F.Hoffmann-La Roche Ltd. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Oncology Biomarker Introduction
12.4.4 F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business (2014-2019)
12.4.5 F.Hoffmann-La Roche Ltd. Recent Development
12.5 Genomic Health
12.5.1 Genomic Health Company Details
12.5.2 Company Description and Business Overview
12.5.3 Oncology Biomarker Introduction
12.5.4 Genomic Health Revenue in Oncology Biomarker Business (2014-2019)
12.5.5 Genomic Health Recent Development
12.6 GlaxoSmithKline plc
12.6.1 GlaxoSmithKline plc Company Details
12.6.2 Company Description and Business Overview
12.6.3 Oncology Biomarker Introduction
12.6.4 GlaxoSmithKline plc Revenue in Oncology Biomarker Business (2014-2019)
12.6.5 GlaxoSmithKline plc Recent Development
12.7 Novartis AG
12.7.1 Novartis AG Company Details
12.7.2 Company Description and Business Overview
12.7.3 Oncology Biomarker Introduction
12.7.4 Novartis AG Revenue in Oncology Biomarker Business (2014-2019)
12.7.5 Novartis AG Recent Development
12.8 Merck & Co.
12.8.1 Merck & Co. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Oncology Biomarker Introduction
12.8.4 Merck & Co. Revenue in Oncology Biomarker Business (2014-2019)
12.8.5 Merck & Co. Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Oncology Biomarker Introduction
12.9.4 Pfizer Revenue in Oncology Biomarker Business (2014-2019)
12.9.5 Pfizer Recent Development
12.10 Qiagen N.V.
12.10.1 Qiagen N.V. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Oncology Biomarker Introduction
12.10.4 Qiagen N.V. Revenue in Oncology Biomarker Business (2014-2019)
12.10.5 Qiagen N.V. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Oncology Biomarker Key Market Segments
Table Key Players Oncology Biomarker Covered
Table Global Oncology Biomarker Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Lung Cancer Figures
Table Key Players of Lung Cancer
Figuer Breast Cancer Figures
Table Key Players of Breast Cancer
Figuer Colorectal Cancer Figures
Table Key Players of Colorectal Cancer
Figuer Prostate Cancer Figures
Table Key Players of Prostate Cancer
Figuer Stomach Cancer Figures
Table Key Players of Stomach Cancer
Figuer Others Figures
Table Key Players of Others
Table Global Oncology Biomarker Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Oncology Biomarker Market Share by Application in 2018 & 2025
Figure Diagnostics Case Studies
Figure Drug Discovery And Development Case Studies
Figure Prognostics Case Studies
Figure Risk Assessment Case Studies
Figure Others Case Studies
Figure Oncology Biomarker Report Years Considered
Figure Global Oncology Biomarker Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Oncology Biomarker Market Size by Regions 2019-2025 (Million US$)
Table Global Oncology Biomarker Market Size by Regions 2019-2025 (Million US$)
Table Global Oncology Biomarker Market Share by Regions 2014-2019
Figure Global Oncology Biomarker Market Share by Regions 2014-2019
Figure Global Oncology Biomarker Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Oncology Biomarker Revenue by by Players (2014-2019) (Million US$)
Table Global Oncology Biomarker Market Share by by Players (2014-2019)
Figure Global Oncology Biomarker Market Share by by Players in 2018
Table Global Oncology Biomarker by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Oncology Biomarker Product/Solution/Service
Table Date of Enter into Oncology Biomarker Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncology Biomarker Market Size by Type (2014-2019) (Million US$)
Table Global Oncology Biomarker Market Size Share by Type (2014-2019)
Figure Global Oncology Biomarker Market Size Market Share by Type (2014-2019)
Table Global Oncology Biomarker Market Size by Application (2014-2019) (Million US$)
Table Global Oncology Biomarker Market Size Share by Application (2014-2019)
Figure Global Oncology Biomarker Market Size Market Share by Application (2014-2019)
Figure Global Oncology Biomarker Revenue Market Share by Application in 2018
Figure North America Oncology Biomarker Market Size 2014-2019 (Million US$)
Table North America Key Players Oncology Biomarker Revenue (2018-2019) (Million US$)
Table North America Key Players Oncology Biomarker Market Share (2018-2019)
Table North America Oncology Biomarker Market Size by Type 2014-2019 (Million US$)
Table North America Oncology Biomarker Market Share by Type 2014-2019
Table North America Oncology Biomarker Market Size by Application 2014-2019 (Million US$)
Table North America Oncology Biomarker Market Share by Application 2014-2019
Figure Europe Oncology Biomarker Market Size 2014-2019 (Million US$)
Table Europe Key Players Oncology Biomarker Revenue (2018-2019) (Million US$)
Table Europe Key Players Oncology Biomarker Market Share (2018-2019)
Table Europe Oncology Biomarker Market Size by Type 2014-2019 (Million US$)
Table Europe Oncology Biomarker Market Share by Type 2014-2019
Table Europe Oncology Biomarker Market Size by Application 2014-2019 (Million US$)
Table Europe Oncology Biomarker Market Share by Application 2014-2019
Figure China Oncology Biomarker Market Size 2014-2019 (Million US$)
Table China Key Players Oncology Biomarker Revenue (2018-2019) (Million US$)
Table China Key Players Oncology Biomarker Market Share (2018-2019)
Table China Oncology Biomarker Market Size by Type 2014-2019 (Million US$)
Table China Oncology Biomarker Market Share by Type 2014-2019
Table China Oncology Biomarker Market Size by Application 2014-2019 (Million US$)
Table China Oncology Biomarker Market Share by Application 2014-2019
Figure Japan Oncology Biomarker Market Size 2014-2019 (Million US$)
Table Japan Key Players Oncology Biomarker Revenue (2018-2019) (Million US$)
Table Japan Key Players Oncology Biomarker Market Share (2018-2019)
Table Japan Oncology Biomarker Market Size by Type 2014-2019 (Million US$)
Table Japan Oncology Biomarker Market Share by Type 2014-2019
Table Japan Oncology Biomarker Market Size by Application 2014-2019 (Million US$)
Table Japan Oncology Biomarker Market Share by Application 2014-2019
Figure Southeast Asia Oncology Biomarker Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Oncology Biomarker Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Oncology Biomarker Market Share (2018-2019)
Table Southeast Asia Oncology Biomarker Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Oncology Biomarker Market Share by Type 2014-2019
Table Southeast Asia Oncology Biomarker Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Oncology Biomarker Market Share by Application 2014-2019
Figure India Oncology Biomarker Market Size 2014-2019 (Million US$)
Table India Key Players Oncology Biomarker Revenue (2018-2019) (Million US$)
Table India Key Players Oncology Biomarker Market Share (2018-2019)
Table India Oncology Biomarker Market Size by Type 2014-2019 (Million US$)
Table India Oncology Biomarker Market Share by Type 2014-2019
Table India Oncology Biomarker Market Size by Application 2014-2019 (Million US$)
Table India Oncology Biomarker Market Share by Application 2014-2019
Figure Central & South America Oncology Biomarker Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Oncology Biomarker Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Oncology Biomarker Market Share (2018-2019)
Table Central & South America Oncology Biomarker Market Size by Type 2014-2019 (Million US$)
Table Central & South America Oncology Biomarker Market Share by Type 2014-2019
Table Central & South America Oncology Biomarker Market Size by Application 2014-2019 (Million US$)
Table Central & South America Oncology Biomarker Market Share by Application 2014-2019
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Oncology Biomarker Business 2014-2019 (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Oncology Biomarker Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Oncology Biomarker Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Oncology Biomarker Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Oncology Biomarker Business 2014-2019 (Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Oncology Biomarker Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table F.Hoffmann-La Roche Ltd. Company Details
Table F.Hoffmann-La Roche Ltd. Revenue in Oncology Biomarker Business 2014-2019 (Million US$)
Figure F.Hoffmann-La Roche Ltd. Revenue Growth Rate in Oncology Biomarker Business (2014-2019)
Table F.Hoffmann-La Roche Ltd. Recent Development
Table Genomic Health Company Details
Table Genomic Health Revenue in Oncology Biomarker Business 2014-2019 (Million US$)
Figure Genomic Health Revenue Growth Rate in Oncology Biomarker Business (2014-2019)
Table Genomic Health Recent Development
Table GlaxoSmithKline plc Company Details
Table GlaxoSmithKline plc Revenue in Oncology Biomarker Business 2014-2019 (Million US$)
Figure GlaxoSmithKline plc Revenue Growth Rate in Oncology Biomarker Business (2014-2019)
Table GlaxoSmithKline plc Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Oncology Biomarker Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Oncology Biomarker Business (2014-2019)
Table Novartis AG Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Revenue in Oncology Biomarker Business 2014-2019 (Million US$)
Figure Merck & Co. Revenue Growth Rate in Oncology Biomarker Business (2014-2019)
Table Merck & Co. Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Oncology Biomarker Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Oncology Biomarker Business (2014-2019)
Table Pfizer Recent Development
Table Qiagen N.V. Company Details
Table Qiagen N.V. Revenue in Oncology Biomarker Business 2014-2019 (Million US$)
Figure Qiagen N.V. Revenue Growth Rate in Oncology Biomarker Business (2014-2019)
Table Qiagen N.V. Recent Development
Table Global Oncology Biomarker Market Size by Regions (Million US$) 2019-2025
Figure Global Oncology Biomarker Market Size Share by Regions (2019-2025)
Figure Global Oncology Biomarker Market Size Share by Regions in 2025
Figure North America Oncology Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure Europe Oncology Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure China Oncology Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure Japan Oncology Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Oncology Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure India Oncology Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Oncology Biomarker Market Size Forecast (2019-2025)(Million USD)
Table Global Oncology Biomarker Market Size by Product (2019-2025) (Million US$)
Figure Global Oncology Biomarker Market Size by Product (2019-2025)
Figure Global Oncology Biomarker Market Size by Product in 2025
Table Global Oncology Biomarker Market Size by Application (2019-2025) (Million US$)
Figure Global Oncology Biomarker Market Size by Application (2019-2025)
Figure Global Oncology Biomarker Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
体外大腸癌スクリーニング検査の世界市場：市場規模・現状・予測 In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.Growing incidences of colon and rectal cancer and the introduction of novel screening tests employing genetic testing are the major factors expected to drive the in-vitro colorectal can…- 小細胞肺がん治療薬の世界市場：市場規模・現状・予測 Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…
- 前立腺癌の世界市場：市場規模・現状・予測 Prostate cancer is cancer that occurs in the prostate.In 2018, the global Prostate Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Prostate Cancer status, future forecast, grow…
- 肺癌液体生検の世界市場：市場規模・現状・予測 Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer.CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time. In 2018, the global Lung Ca…
- ホルモン不応性前立腺癌(HRPCA)の世界市場：市場規模・現状・予測 Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …